Scientists are developing a smartphone app that they say can accurately detect Down syndrome in infants soon after birth. Down syndrome, a genetic disorder that affects about 1-in-1,000 children worldwide, causes physical and intellectual disabilities. Early detection is beneficial to the development of children with the disorder, but that requires sophisticated medical tests not available everywhere. In developed countries, Down syndrome is often detected during prenatal screenings. But in less-developed countries, these tests are often not available. Marius Linguraru, a principal investigator at Washington’s Sheikh Zayed Institute for Pediatric Surgical Innovation, said genetic defects can be hard to diagnose after a baby is born.
Full Photo Gallery
Want the latest Children's National news and stories as they happen? Sign up to get our News & Events releases by email.
A preclinical study led by researchers at Children’s National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy (DMD).
A team of researchers from Children’s National Health System used 3-D volumetric magnetic resonance imaging (MRI) in an innovative study that reported that when the placenta fails to grow adequately in a fetus with congenital heart disease (CHD), it contributes to impaired fetal growth and premature birth.
Pediatric specialists at Children’s National work closely to ensure an integrated approach to caring for each child and family.
A study by researchers at Children’s National Health System provides direct evidence that targeting specific receptors in white matter cells after brain injury promotes cellular and functional recovery.